CHRS · Coherus Oncology, Inc. · Executive Compensation
$0.77
+0.02 (+2.82%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$118.97M
Shares
154.50M
Volume · Nov 6
1.08M
Avg daily vol (3M)
1.45M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Dennis Lanfear | President, Chief Executive Office and Chairman of the Board of Directors | $5,361,707 |
| Darlene P. Horton | former Chief Medical and Regulatory Affairs Officer | $3,629,789 |
| Jean-Frédéric Viret | Chief Financial Officer | $1,829,591 |
| Vincent Anicetti | Chief Operating Officer | $1,810,841 |
| Vladimir Vexler | Chief Scientific Officer | $1,757,229 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Vincent Anicetti | Chief Operating Officer | $1,818,680 |
| Vladimir Vexler | Chief Scientific Officer | $1,355,163 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michael Ryan | Class II director | Appointed | 2025-04-25 |
| Rita A. Karachun | Class II director | Resigned | 2025-04-25 |
| Rita A. Karachun | Class I director | Appointed | 2025-04-25 |
| Michael Ryan | Class III director | Resigned | 2025-04-25 |
| Paul Reider | Chief Commercial Officer | Resigned | 2025-04-22 |
| Kimberly J. Tzoumakas | Board of Directors | Resigned | 2024-12-04 |
| Bryan McMichael | Chief Financial Officer | Appointed | 2024-08-08 |
| Rita A. Karachun | Class II director | Appointed | 2024-06-05 |
| Georgia Erbez | Class III director | Appointed | 2024-02-22 |
| Bryan McMichael | Interim Chief Financial Officer and Principal Financial Officer | Appointed | 2023-12-11 |
| McDavid Stilwell | Chief Financial Officer, Principal Financial Officer | Resigned | 2023-12-07 |
| Michael Ryan | Class III director | Appointed | 2023-07-20 |
| Vladimir Vexler, Ph.D. | Chief Scientific Officer | Resigned | 2023-03-06 |
| Bryan McMichael | Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer | Appointed | 2022-09-09 |
Leadership
- Dennis Lanfear CEO
- Bryan McMichael CFO, Chief Accounting Officer
- Alan C. Mendelson Board Member
- Charles Newton Board Member
- Georgia Erbez Board Member
- Jill O'Donnell-Tormey, Ph.D. Board Member
- Lee N. Newcomer Board Member
- Mark D. Stolper Board Member
- Michael Ryan Board Member
- Rita A. Karachun Board Member
Key facts
CIK
1512762
CUSIP
19249H103
13F (30d)
72 filings
49 filers
Visit website
Investor relations